RVPH Reviva Pharmaceuticals Holdings, Inc.

Fundamentals / CIK 0001742927 / USD

Reviva Pharmaceuticals Holdings, Inc. reported $18.56M in total assets and a net loss of $11.31M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RVPH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2019 to 2025), reported in USD.

$4.75M$2.38M$0-$36.76MFY 2019 Net Income: $574K2019FY 2019 Net Income: -$847K2019FY 2020 Net Income: $618K2020FY 2020 Net Income: -$3.78M2020FY 2021 Net Income: -$8.52M2021FY 2021 Net Income: -$8.52M2021FY 2022 Net Income: -$28.26M2022FY 2023 Net Income: -$39.26M2023FY 2024 Net Income: -$29.92M2024FY 2025 Net Income: -$19.86M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 13 Dec 31 Feb 29 Dec 31 Feb 28
Research & Development $11.71M $22.91M $31.42M $22.87M $4.85M $4.85M $295K -- $196K --
Total Operating Expenses $20.20M $30.80M $39.50M $28.23M $10.10M $10.10M $2.43M $725K $377K $153K
Operating Income -$20.20M -$30.80M -$39.50M -$28.23M -$10.10M -$10.10M -$2.43M -$725K -$377K -$153K
EBITDA -- -- -- -- -$10.10M -- -$2.43M -- -$376K --
Interest Income $311K $361K $398K -- -- -- $105K $1.32M $201 $729K
Interest Expense $13K $18K $34K -- -- $0 $1.45M -- $469K --
Income Before Tax -$19.85M -$29.90M -$39.24M -$28.24M -$8.52M -$8.52M -$3.78M -- -$846K --
Income Tax Expense $19K $20K $17K $21K $6.0K $6.0K $800 $0 $800 --
Net Income -$19.86M -$29.92M -$39.26M -$28.26M -$8.52M -$8.52M -$3.78M $618K -$847K $574K
Basic EPS -$5.48 -$17.73 -$32.42 -$28.49 -$11.39 -$11.39 -$24.36 -$4.13 -$6.09 -$0.79
Diluted EPS -- -- -- -- -- -$11.39 -$24.36 -$4.13 -$6.09 -$0.79
Basic Shares Outstanding 3.6M 1.7M 1.2M 993.4K 752.9K 752.9K 155.8K 132.9K 140.9K 103.8K
Diluted Shares Outstanding -- -- -- -- -- 752.9K 155.8K 132.9K 140.9K 103.8K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.20M $1.39M $1.44M $1.74M $2.13M $3.72M $4.11M $4.68M
Total Operating Expenses $2.43M $2.62M $3.27M $3.56M $4.03M $6.07M $6.54M $6.28M
Operating Income -$2.43M -$2.62M -$3.27M -$3.56M -$4.03M -$6.07M -$6.54M -$6.28M
Interest Income $135K $176K $89K $143K $59K $23K $86K $47K
Interest Expense $1.2K $2.9K $6.7K -$5.6K $2.6K $4.8K $12K $4.7K
Income Before Tax -$2.30M -$2.45M -$3.19M -$3.36M -$4.01M -$6.05M -$6.43M -$6.25M
Income Tax Expense $1.9K $2.6K $3.3K $2.9K $2.8K $8.0K $5.2K $4.7K
Net Income -$2.30M -$2.45M -$3.20M -$3.37M -$4.01M -$6.05M -$6.43M -$6.26M
Basic EPS -$0.17 -$0.19 -$0.46 -- -$1.09 -$2.40 -$2.61 --
Basic Shares Outstanding 13.2M 13.2M 7.0M -- 3.7M 2.5M 2.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Feb 29 Dec 31 Feb 28
Cash & Cash Equivalents $14.44M $13.48M $23.37M $18.52M $29.69M $8.76M $69K $193 $313K
Cash & Short-Term Investments $14.44M $13.48M $23.37M $18.52M $29.69M $8.76M $69K $193 $313K
Total Current Assets $15.10M $14.68M $23.70M -- -- -- $139K -- $404K
Property, Plant & Equipment, Net -- -- -- -- -- $0 -- $591 --
Total Non-Current Assets $820K $820K $0 -- -- -- $60.88M -- $65.24M
Total Assets $15.92M $15.50M $23.70M $18.92M $31.40M $8.76M $61.02M $2.6K $65.65M
Accounts Payable $3.01M $6.28M $3.85M $3.52M $510K $1.01M $300K $225K $23K
Short-Term Debt $407K $458K $0 $0 -- -- -- -- --
Total Current Liabilities $7.28M $14.60M $17.18M $9.96M $2.34M $1.33M $300K -- $23K
Total Non-Current Liabilities $0 $89K $807K $567K $373K $1.96M $2.96M -- $2.21M
Total Liabilities $7.28M $14.69M $17.98M $10.53M $2.72M $3.30M $3.26M $6.81M $2.24M
Total Debt (incl. Leases) $407K $458K $0 $0 -- -- -- -- --
Common Stock $12K $4.7K $2.8K $2.0K $1.4K $923 $3.81M $618 $4.43M
Retained Earnings -$184.1M -$164.3M -$134.4M -$95.09M -$66.83M -$58.31M $1.19M -$54.53M $574K
Total Stockholders' Equity $8.65M $813K $5.72M $8.39M $28.69M $5.47M $5.00M -$6.81M $5.00M
Total Equity $8.65M $813K $5.72M $8.39M $28.69M $5.47M $5.00M -$6.81M $5.00M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $17.46M $19.89M $22.19M $14.44M $13.18M $10.36M $5.29M $13.48M
Cash & Short-Term Investments $17.46M $19.89M $22.19M $14.44M $13.18M $10.36M $5.29M $13.48M
Total Current Assets $18.56M $21.14M $23.56M $15.10M $13.51M $10.82M $6.26M $14.68M
Total Non-Current Assets $0 $0 $0 $820K $820K $820K $820K $820K
Total Assets $18.56M $21.14M $23.56M $15.92M $14.33M $11.63M $7.08M $15.50M
Accounts Payable $2.48M $2.46M $2.09M $3.01M $5.43M $4.97M $4.72M $6.28M
Short-Term Debt $44K $144K $231K $407K $0 $113K $224K $458K
Total Current Liabilities $5.48M $5.93M $6.12M $7.28M $9.74M $12.08M $11.51M $14.60M
Total Non-Current Liabilities $0 $0 $0 $0 $45K $17K $28K $89K
Total Liabilities $5.48M $5.93M $6.12M $7.28M $9.78M $12.09M $11.54M $14.69M
Total Debt (incl. Leases) $44K $144K $231K $407K $0 $113K $224K $458K
Common Stock $12K $12K $12K $12K $9.6K $6.8K $4.7K $4.7K
Retained Earnings -$192.1M -$189.8M -$187.3M -$184.1M -$180.8M -$176.8M -$170.7M -$164.3M
Total Stockholders' Equity $13.08M $15.21M $17.44M $8.65M $4.55M -$459K -$4.46M $813K
Total Equity $13.08M $15.21M $17.44M $8.65M $4.55M -$459K -$4.46M $813K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 13 Dec 31 Feb 29 Dec 31 Feb 28
Net Income -$19.86M -$29.92M -$39.26M -$28.26M -$8.52M -$8.52M -$3.78M $618K -$847K $574K
Depreciation & Amortization -- -- -- -- $0 -- $591 -- $645 --
Stock-Based Compensation $2.23M $1.63M $3.41M $177K $107K -- $0 -- $0 --
Change in Payables -$3.41M $2.29M $329K $3.01M -$498K -- $775K $277K $158K $23K
Operating Cash Flow -$24.59M -$33.54M -$28.32M -$18.96M -$10.67M -- -$4.07M -$427K -$218K -$221K
Investing Cash Flow -- -- -- -- -- -- -- $5.70M -- -$64.52M
Common Stock Issued -- -- -- -- $31.50M -- $0 -- -- $25K
Share Repurchases -- -- -- -- -- -- -- -$6.27M -- --
Financing Cash Flow $25.56M $23.65M $33.17M $7.79M $31.60M -- $12.83M -$5.52M $100K $65.05M
Net Change in Cash $962K -$9.89M $4.85M -$11.17M $20.93M -- $8.76M -$244K -$118K $313K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.30M -$2.45M -$3.20M -$3.37M -$4.01M -$6.05M -$6.43M -$6.26M
Stock-Based Compensation $171K $215K $584K $455K $458K $395K $919K $554K
Change in Payables $165K $278K -$976K -$2.20M $325K $27K -$1.56M -$2.64M
Operating Cash Flow -$2.18M -$2.12M -$3.80M -$5.80M -$5.59M -$5.01M -$8.19M -$9.10M
Financing Cash Flow -$247K -$185K $11.55M $7.05M $8.41M $10.09M $7.3K $17.02M
Net Change in Cash -$2.43M -$2.30M $7.75M $1.26M $2.82M $5.07M -$8.19M $7.92M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 13 Dec 31 Feb 29 Dec 31 Feb 28
Return on Equity (ROE) -229.7% -3682.0% -686.5% -336.7% -29.7% -29.7% -69.2% 12.4% -- 11.5%
Return on Assets (ROA) -124.8% -193.0% -165.7% -149.3% -27.1% -27.1% -43.2% 1.0% -32570.5% 0.9%
Current Ratio 2.08x 1.01x 1.38x -- -- -- -- 0.46x -- 17.53x
Quick Ratio 1.98x 0.92x 1.36x 1.86x 12.66x 12.66x 6.57x 0.23x -- 13.58x
Debt to Equity 0.05x 0.56x 0.00x 0.00x -- -- -- -- -- --
Net Income Growth (YoY) -- -- -- -- -- -- -- +7.6% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -86.5% -85.6% -95.3% -229.7% -500.2% -- -- -3682.0%
Return on Assets (ROA) -60.9% -61.6% -70.6% -124.8% -158.8% -233.0% -408.6% -193.0%
Current Ratio 3.39x 3.56x 3.85x 2.08x 1.39x 0.90x 0.54x 1.01x
Quick Ratio 3.19x 3.35x 3.63x 1.98x 1.35x 0.86x 0.46x 0.92x
Debt to Equity 0.00x 0.01x 0.01x 0.05x 0.00x -- -- 0.56x
Source: SEC EDGAR CompanyFacts (CIK 0001742927) · from May 31, 2018 Data through September 30, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal